Finecare NT-proBNP Quantitative Test Device

Finecare NT-proBNP Quantitative Test Device

Finecare NT-proBNP Rapid Quantitative Test is a CLIA-based point-of-care testing (POCT) device for the quantitative measurement of NT-proBNP in human serum or plasma, helping in the early detection and monitoring of heart failure.

Overview: The Finecare NT-proBNP Rapid Quantitative Test Device is a cutting-edge diagnostic solution designed for the quantitative detection of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in human serum or plasma. Using Chemiluminescence Immunoassay (CLIA) technology, this POCT device provides accurate, reliable results in just 15 minutes, making it ideal for early diagnosis of heart failure and cardiac function assessment in emergency, outpatient, and clinical settings.

Key Features:

• Quantitative detection of NT-proBNP, a key cardiac biomarker

• Rapid results within 15 minutes

• High sensitivity & precision with CLIA-based technology

• Suitable for serum or plasma samples

• Compatible with Finecare FIA Meters

• Designed for use in cardiology, ER, ICU, and outpatient clinics.

Clinical Applications:

• Early detection of heart failure (HF)

• Risk stratification for patients with acute coronary syndrome

• Monitoring of cardiac function in chronic heart disease

• Differentiation of cardiac vs non-cardiac dyspnea

Specifications:

• Sample Type: Human serum or plasma

• Testing Method: Chemiluminescence Immunoassay (CLIA)

• Result Time: Approximately 15 minutes

• Measuring Range: Defined by Finecare analyzer

• Storage Conditions: 2°C – 30°C

• Shelf Life: 18–24 months

• Compatible Equipment: Finecare FIA Meter II / III

Packaging:

• 25 Tests/Kit – includes all required testing components

Instructions for Use:

1. Collect blood sample and separate serum/plasma.

2. Load sample onto test cartridge.

3. Insert cartridge into Finecare FIA Meter.

4. Read and interpret the result within 15 minutes.